Rolziracetam

Rolziracetam

Systematic (IUPAC) name
dihydro-1H-pyrrolizine-3,5(2H,6H)-dione
Clinical data
Legal status	Unscheduled (US)
Routes of administration	Oral
Identifiers
CAS Registry Number	18356-28-0 N
ATC code	None
PubChem	CID 71893
ChemSpider	64906 Y
UNII	RES9I0LGG5 Y
ChEMBL	CHEMBL51396 Y
Synonyms	2,6,7,8-tetrahydro-1H-pyrrolizine-3,5-dione
Chemical data
Formula	C7H9N2O2
Molecular mass	139.152 g/mol
SMILES O=C2N1C(=O)CCC1CC2
InChI InChI=1S/C7H9NO2/c9-6-3-1-5-2-4-7(10)8(5)6/h5H,1-4H2  Y Key:IEZDOKQWPWZVQF-UHFFFAOYSA-N  Y
N (what is this?)  (verify)

Rolziracetam is a nootropic drug of the racetam family.

Rolziracetam was found to improve performance on a delayed-response task in aged rhesus monkeys. It has a wide margin of safety in animals and has been evaluated for use in cognitively impaired human subjects. ^[1]

See also

• Piracetam

References

1. ↑ Butler DE, Leonard JD, Caprathe BW, L'Italien YJ, Pavia MR, Hershenson FM, Poschel PH, Marriott JG. Amnesia-reversal activity of a series of cyclic imides. Journal of Medicinal Chemistry. 1987 Mar;30(3):498-503.